-
Catalog
C001856
-
Alternative name
Insulin-like growth factor 2 mRNA-binding protein 3 CLIA KIT; IGF-II mRNA-binding protein 3 CLIA KIT; KH domain-containing protein overexpressed in cancer CLIA KIT; hKOC CLIA KIT; VICKZ family member 3IGF2BP3 CLIA KIT; IMP3 CLIA KIT; KOC1 CLIA KIT; VICKZ3 CLIA KIT; IGF2 mRNA-binding protein 3 CLIA KIT; IMP-3 CLIA KIT; hKOC CLIA KIT
-
GeneIGF2BP3
-
Species ReactivityHuman
-
SpecificityThis assay has high sensitivity and excellent specificity for detection of Insulin Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3).
No significant cross-reactivity or interference between Insulin Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3) and analogues was observed.
-
SamplesTissue homogenates and other biological fluids
-
Detection Range27.43-20000pg/mL
-
SensitivityThe minimum detectable dose of this kit is typically less than 9.91pg/mL.
-
PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Insulin Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Insulin Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
-
Product Description specificalPrinciple of the Assay: The microtiter plate provided in this kit has been pre-coated with an antigen. Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated secondary antibody. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Insulin Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3) level in the sample or standard.
-